Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole + clomiphene citrate versus letrozole + gonadotropin for ovulation induction in clomiphene-resistant PCOS
PACTR202511544935228Completed
- Sponsor
- Tanta University
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of letrozole and clomiphene in polycystic ovary syndrome (PCOS) and female infertility (2 arms), sponsored by Tanta University. Primary endpoint: Ovulation rate. Started Dec 2022; status: completed.
02
Drugs
letrozoleclomiphene
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on PACTR202511544935228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511544935228.